Ligand Pharmaceuticals Inc (LGNZZ) — 10-K Filings
All 10-K filings from Ligand Pharmaceuticals Inc. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Ligand Pharmaceuticals Files 2024 Annual Report
— Feb 28, 2025 Risk: medium
Ligand Pharmaceuticals Inc. reported its 2024 fiscal year results on February 28, 2025. The company's primary business involves licensing its drug discovery tec -
Ligand Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K
— Feb 29, 2024 Risk: medium
LIGAND PHARMACEUTICALS INC (LGNZZ) filed a Annual Report (10-K) with the SEC on February 29, 2024. Ligand Pharmaceuticals Inc. reported its 2023 fiscal year res
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX